• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
How AIDS Activists Challenged America (and Saved FDA from Itself): A History and Memoir

How AIDS Activists Challenged America (and Saved FDA from Itself): A History and Memoir

9781680531404
986.58 zł
887.92 zł Save 98.66 zł Tax included
Lowest price within 30 days before promotion: 887.92 zł
Quantity
Product unavailable
Temporarily unavailable

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this extraordinary history, James Driscoll reveals the untold story of how AIDS activists, by thwarting bureaucratic plans imposed by the U.S. Federal Drug Administration (FDA), both saved HIV patients and rescued the FDA itself from a self-inflicted public health catastrophe. By 1996, accelerated approval of AIDS drug cocktails transformed AIDS from a death sentence to a manageable disease. That approval, however, came only after years of struggle pitting AIDS activists against the hidebound culture of the Food and Drug Administration, which wanted to run lengthy efficacy trials required for full approval and possibly delay the drugs at a cost of tens of thousands of lives. Driscoll’s courageous efforts, which are an important personal part of the story, navigated conflicts among AIDS activist groups as they struggled with both major American political parties to be heard and respected. He examines the effect of AIDS activism on the LGBT community, its views of itself, and its place in modern American society. Additional materials analyze FDA mistakes, drug pricing, and other contemporary challenges for the LGBTs community.
Product Details
Eurospan
82597
9781680531404
9781680531404

Data sheet

Publication date
2020
Issue number
1
Cover
hard cover
Comments (0)